Article
CRISPR‐interceded CHO cell line development approaches
3 Jan 2023
Abstract excerpt
For industrial production of recombinant protein biopharmaceuticals, Chinese hamster ovary (CHO) cells represent the most widely adopted host cell system, owing to their capacity to produce high-quality biologics with human-like posttranslational modifications. As opposed to random integration, targeted genome editing in genomic safe harbor sites has offered CHO cell line engineering a new perspective, ensuring...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
